Blake Borgeson - Net Worth and Insider Trading
Blake Borgeson Net Worth
The estimated net worth of Blake Borgeson is at least $32 Million dollars as of 2025-05-06. Blake Borgeson is the Director of Recursion Pharmaceuticals Inc and owns about 7,066,113 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $32 Million. Details can be seen in Blake Borgeson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Blake Borgeson has not made any transactions after 2024-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Blake Borgeson
Blake Borgeson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Blake Borgeson owns 1 companies in total, including Recursion Pharmaceuticals Inc (RXRX) .
Click here to see the complete history of Blake Borgeson’s form 4 insider trades.
Insider Ownership Summary of Blake Borgeson
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2024-11-12 | director |
Blake Borgeson Latest Holdings Summary
Blake Borgeson currently owns a total of 1 stock. Blake Borgeson owns 7,066,113 shares of Recursion Pharmaceuticals Inc (RXRX) as of November 12, 2024, with a value of $32 Million.
Latest Holdings of Blake Borgeson
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2024-11-12 | 7,066,113 | 4.47 | 31,585,525 |
Holding Weightings of Blake Borgeson
Blake Borgeson Form 4 Trading Tracker
According to the SEC Form 4 filings, Blake Borgeson has made a total of 56 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 56 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 11,447 shares on November 12, 2024, which brought Blake Borgeson around $87,455.
Insider Trading History of Blake Borgeson
- 1
Blake Borgeson Trading Performance
Blake Borgeson Ownership Network
Ownership Network List of Blake Borgeson
Ownership Network Relation of Blake Borgeson
Blake Borgeson Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Blake Borgeson is the director of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , Chief Financial Officer Michael Secora , and President and COO Tina Marriott Larson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Blake Borgeson made 27 insider transaction in Recursion Pharmaceuticals Inc (RXRX) with a net sale of 366,756. Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 1,188,847 shares made by Christopher Gibson , a net sale of 478,124 shares made by Michael Secora , and a net sale of 71,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 178,574 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 178,574 shares. During the past 18 months, 2,207,868 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,207,868 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Blake Borgeson Mailing Address
Above is the net worth, insider trading, and ownership report for Blake Borgeson. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Blake Borgeson's mailing address is: Salt Lake City Ut 84101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
